/DaVita%20Inc%20sign%20on%20building-by%20photo-denver%20via%20Shutterstock.jpg)
With a market cap of $10 billion, DaVita Inc. (DVA) provides kidney dialysis and related laboratory services for patients with chronic kidney failure, primarily through outpatient centers. It also offers integrated care, clinical research, physician services, and comprehensive kidney care, including home-based and hospital dialysis options.
The Denver, Colorado-based is set to announce its fiscal Q1 2026 results after the market closes on Monday, May 11. Ahead of this event, analysts expect DVA to report an adjusted EPS of $2.41, an increase of 20.5% from $2 in the year-ago quarter. It has surpassed Wall Street's earnings estimates in three of the last four quarters while missing on another occasion.